OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED

COR2ED brings you Independent Medical Education from OBSTETRICS & GYNECOLOGY CONNECT, experts in obstetrics & gynecology

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

📣 New video!
Understanding HER2 testing in gynecological cancers

Prof. Fernando Soares provides a guideline-based overview 📺

View/download the slides for more details: https://t.co/irOwaUTuwZ

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #MedTwitter #precisionmedicine

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

As HER2-targeted treatment options continue to expand in gynaecological cancers.

Prof. Fernando Soares provides practical guidance on HER2 IHC testing, scoring, and how HER2 status can inform treatment decisions.

#MedEd

[PRECISION ONCOLOGY CONNECT powered by COR2ED @PresOnc_Connect]

➡️ HER2 IHC testing is recommended in p53-aberrant endometrial carcinoma

➡️ It may be considered in selected advanced/recurrent cervical & ovarian cancers when evaluating eligibility for HER2-targeted therapies

🧬 Find out more about #HER2 testing in gynecological cancers, best practice, & treatment selection

📺 From Prof. Fernando Soares

Get the slides for more: https://t.co/aeqP7LQjSE

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #MedTwitter #precisionmedicine

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

➡️ HER2 IHC testing is recommended in p53-aberrant endometrial carcinoma

➡️ It may be considered in selected advanced/recurrent cervical & ovarian cancers when evaluating eligibility for HER2-targeted therapies

🧬 Find out more about #HER2 testing in gynecological cancers, best practice, & treatment selection

📺 From Prof. Fernando Soares

Get the slides for more: https://t.co/irOwaUU2mx

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #MedTwitter #precisionmedicine

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

📺 Endometrial cancer update from Prof. Domenica Lorusso

✔️ Navigating recent ESGO guidelines
✔️ Implications for clinical practice

What do HCPs need to know about treatment selection in advanced endometrial cancer?

📺 Watch the video to find out!

View the slides: https://t.co/UB06f8978d

🤝 Programme endorsed by @WarOnCancer

Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content

#MedEd #MedTwitter #endometrialcancer

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Understanding HER2 testing in gynecological cancers: Best practices and treatment implications

✔️ Get a guideline-driven overview of immunohistochemistry testing in endometrial, cervical & ovarian cancers

✔️ Find out why accurate assessment is now critical for treatment selection

📺 From Prof. Fernando Soares

Get the slides for more details: https://t.co/irOwaUU2mx

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #MedTwitter

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Optimising treatment selection in advanced endometrial cancer

📺 Expert video from Prof. Domenica Lorusso

Explore ESGO guidelines & what they mean for clinical practice

-Clinical relevance of molecular subtypes/their role in risk stratification & treatment planning
-Tx algorithms for advanced/recurrent disease, inc. distinctions between dMMR/non-dMMR tumours
-pembrolizumab + lenvatinib as a chemotherapy-free option for selected pts
-Established systemic treatment strategies across molecular subgroups

View the slides: https://t.co/UB06f8978d

🤝 Programme endorsed by @WarOnCancer

Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content

#MedEd #obgyn #OncTwitter

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Precision oncology in gynecological cancers – a MedEd programme for HCPs

📺 Explore HER2 testing in endometrial, cervical & ovarian cancers

>> Guideline-based overview, best practice & treatment implications

w/ Prof. Fernando Soares

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Precision oncology in gynecological cancers – a MedEd programme for HCPs

📺 Explore HER2 testing in endometrial, cervical & ovarian cancers

>> Guideline-based overview, best practice & treatment implications

w/ Prof. Fernando Soares

https://t.co/irOwaUU2mx

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #OncTwitter #precisiononcology

[PRECISION ONCOLOGY CONNECT powered by COR2ED @PresOnc_Connect]

HER2 testing is recommended in range of gynecological cancers.

Prof. Fernando Soares shares a practical, guideline-based overview of HER2 IHC testing and scoring across endometrial, cervical & ovarian cancers, and what it means for treatment selection.

📷 Watch the full video here:

https://t.co/3O3weFXbo0

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #GynecologicOncology #PrecisionMedicine

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Prof. Domenica Lorusso provides a concise, guideline-based overview of how molecular classification and clinical trial data inform treatment selection in advanced #endometrialcancer

📺 Watch the video

View the slides: https://t.co/UB06f89EXL

🤝 Programme endorsed by @WarOnCancer

Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content

#MedEd #obgyn

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

ESGO guidelines recommend ICI + chemotherapy followed by maintenance ICI ± PARPi for advanced/recurrent non-dMMR (pMMR) #endometrialcancer

But what if chemotherapy is contraindicated?

Get an update on the ESGO guidelines and how they translate to clinical practice

📺 Video from Prof. Domenica Lorusso

View the slides: https://t.co/UB06f89EXL

🤝 Programme endorsed by @WarOnCancer

Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content

#MedEd #obgyn #endometrialcancer

[PRECISION ONCOLOGY CONNECT powered by COR2ED @PresOnc_Connect]

We are delighted to receive a programme endorsement from the Gynecologic Oncology Trial and Investigation Consortium (GOTIC) once again.

Check out the programme ⬇️
Understanding HER2 testing in gynecological cancers: best practices and treatment implications >> https://t.co/aeqP7LQjSE

We greatly appreciate and value the longstanding collaboration with GOTIC over the past 7 years! We look forward to many more to come 🤝

Programme supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedicalEducation #precisionmedicine 📷

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Exploring best practice in HER2 testing in gynecological cancers

What are the guidelines around HER2 IHC testing & scoring in endometrial, cervical & ovarian cancers?

How does HER2 status impact treatment selection?

Prof. Fernando Soares answers these questions in a guideline-based overview

📺 Video in this post

🔗 Slides >> https://t.co/irOwaUTuwZ

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #OncTwitter #precisiononcology

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

📺 Endometrial cancer update from Prof. Domenica Lorusso

✔️ Navigating recent ESGO guidelines
✔️ Implications for clinical practice

View the slides: https://t.co/UB06f89EXL

🤝 Programme endorsed by @WarOnCancer

Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content

#MedEd #obgyn #endometrialcancer

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Understanding HER2 testing in gynecological cancers: Best practices and treatment implications

- Get a guideline-driven overview of immunohistochemistry testing in endometrial, cervical & ovarian cancers

- Find out why accurate assessment is now critical for treatment selection

📺 From Prof. Fernando Soares

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

📣 New video!
Understanding HER2 testing in gynecological cancers

Prof. Fernando Soares provides a guideline-based overview 📺

View/download the slides for more details: https://t.co/irOwaUTuwZ

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #MedTwitter #precisionmedicine

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

➡️ HER2 IHC testing is recommended in p53-aberrant endometrial carcinoma

➡️ It may be considered in selected advanced/recurrent cervical & ovarian cancers when evaluating eligibility for HER2-targeted therapies

🧬 Find out more about #HER2 testing in gynecological cancers, best practice, & treatment selection

📺 From Prof. Fernando Soares

Get the slides for more: https://t.co/irOwaUTuwZ

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #MedTwitter #precisionmedicine

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Optimising treatment selection in advanced #endometrialcancer

Prof. Domenica Lorusso shares insights on how to navigate recent ESGO guidelines and the implications for clinical practice.

📺 Video in this post!

View the slides: https://t.co/UB06f89EXL

🤝 Programme endorsed by @WarOnCancer

Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content

#MedEd #obgyn #endometrial

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

You can review the latest ESGO guidelines for advanced endometrial cancer in one clear, evidence based resource based resource:

#GynecologicOncology #ESGO2026

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Optimising treatment selection in advanced endometrial cancer

📺 Expert video from Prof. Domenica Lorusso

Explore ESGO guidelines & what they mean for clinical practice

-Clinical relevance of molecular subtypes/their role in risk stratification & treatment planning
-Tx algorithms for advanced/recurrent disease, inc. distinctions between dMMR/non-dMMR tumours
-pembrolizumab + lenvatinib as a chemotherapy-free option for selected pts
-Established systemic treatment strategies across molecular subgroups

View the slides: https://t.co/UB06f8978d

🤝 Programme endorsed by @WarOnCancer

Supported by an Independent Educational Grant from Eisai Europe Limited. Eisai Europe Limited has financially supported this activity and has had no influence on its creation or content

#MedEd #obgyn #OncTwitter

[OBSTETRICS & GYNECOLOGY CONNECT powered by COR2ED @OBGynConnect]

Understanding HER2 testing in gynecological cancers: Best practices and treatment implications

✔️ Get a guideline-driven overview of immunohistochemistry testing in endometrial, cervical & ovarian cancers

✔️ Find out why accurate assessment is now critical for treatment selection

📺 From Prof. Fernando Soares

Get the slides for more details: https://t.co/irOwaUTuwZ

Supported by an Independent Educational Grant from Daiichi Sankyo. For HCPs only.

#MedEd #obgyn #MedTwitter